Key Metrics
2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.89
5-Year SI
5-year SI
- N/A 2-year SI
- 0.89 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
7 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Indexed in the following public directories
-
Scopus -
DOAJ
Topics Covered
- Thalassemia
- Hemophagocytic lymphohistiocytosis
- Cold Agglutinin
- Acute chest syndrome
- Pediatric population
- Intensive care unit
- Vaso-occlusive crisis
- Cold agglutinin disease
Journal Specifications
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Publication Time | 30 |
| Editorial Review Process | Double blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), Associazione Italo-Brasiliana di Ematologia (AIBE), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE) |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 30 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Double blind peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in Hematology, Transfusion and Cell Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
TRATAMENTO DA LEUCEMIA MIELÓIDE CRÔNICA COM INIBIDORES DE TIROSINO QUINASE EM SEGUNDA LINHA
- 1 Oct 21
- Hematology, Transfusion and Cell Therapy
-
Full paper
OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ACCORDING TO THE REASONS FOR INITIATION OF FIRST-LINE TREATMENT: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL
- 1 Oct 21
- Hematology, Transfusion and Cell Therapy
-
Full paper
EVOLUÇÃO DOS CANDIDATOS À DOAÇÃO DE SANGUE DO GÊNERO FEMININO NO BANCO DE SANGUE DO HOSPITAL SANTA MARCELINA EM 10 ANOS
- 1 Oct 21
- Hematology, Transfusion and Cell Therapy
-
Full paper
SUBGROUP ANALYSES OF ELDERLY PATIENTS AGED 70 YEARS IN MAGNIFY: A PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA
- 1 Oct 21
- Hematology, Transfusion and Cell Therapy
-
Full paper
RECIDIVA DE LEUCEMIA MIELOIDE AGUDA (LMA) COM ACOMETIMENTO EM SISTEMA NERVOSO CENTRAL (SNC): RELATO DE CASO
- 1 Oct 21
- Hematology, Transfusion and Cell Therapy
-
Full paper
TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D (GPRC5D) CD3 BISPECIFIC ANTIBODY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 STUDY RESULTS
- 1 Oct 21
- Hematology, Transfusion and Cell Therapy
Scite analysis
Powered by scite_
6k articles received 2.6k citations see all
- 143 Supporting
- 2,125 Mentioning
- 16 Contrasting
Editorial notices
- 1 Retractions
- 2 Withdrawals
- 0 Corrections
- 2 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
7%
4 to 6 months
30%
7 to 9 months
44%
Above 9 months
20%
Did you find this useful?
Thank you for your feedback.
FAQs
How many articles did Hematology, Transfusion and Cell Therapy publish last years ?
In 2023, Hematology, Transfusion and Cell Therapy published articles.
What is the eISSN & pISSN for Hematology, Transfusion and Cell Therapy ?
For Hematology, Transfusion and Cell Therapy,eISSN is 2531-1387 and pISSN is2531-1379.
What is Citescore for Hematology, Transfusion and Cell Therapy ?
Citescore for Hematology, Transfusion and Cell Therapy is 2.
Who is the publisher of Hematology, Transfusion and Cell Therapy ?
Elsevier is the publisher of Hematology, Transfusion and Cell Therapy.